Your browser doesn't support javascript.
loading
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).
Danese, Silvio; Vermeire, Séverine; Hellstern, Paul; Panaccione, Remo; Rogler, Gerhard; Fraser, Gerald; Kohn, Anna; Desreumaux, Pierre; Leong, Rupert W; Comer, Gail M; Cataldi, Fabio; Banerjee, Anindita; Maguire, Mary K; Li, Cheryl; Rath, Natalie; Beebe, Jean; Schreiber, Stefan.
Afiliação
  • Danese S; Gastrointestinal Immunopathology Lab and IBD Unit, Humanitas Clinical and Research Center and Humanitas University, Milan, Italy.
  • Vermeire S; Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
  • Hellstern P; Nature Coast Clinical Research, Inverness, Florida, USA.
  • Panaccione R; Inflammatory Bowel Disease Clinic, University of Calgary, Calgary, Canada.
  • Rogler G; Department of Gastroenterology and Hepatology, University of Zürich, Zürich, Switzerland.
  • Fraser G; Division of Gastroenterology, Rabin Medical Center, University of Tel-Aviv, Petah Tikva, Israel.
  • Kohn A; UOC Gastroenterologia, AO San Camillo Forlanini, Rome, Italy.
  • Desreumaux P; Lille University School of Medicine, University of Lille, Inserm U995, Lille, France.
  • Leong RW; Inflammatory Bowel Diseases Service, Concord Hospital, Sydney, New South Wales, Australia.
  • Comer GM; Formerly of Worldwide Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Cataldi F; Formerly of Worldwide Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Banerjee A; Worldwide Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Maguire MK; Worldwide Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Li C; Worldwide Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Rath N; Worldwide Research and Development, Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Beebe J; Worldwide Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Schreiber S; Department of Medicine I, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
Gut ; 68(1): 40-48, 2019 01.
Article em En | MEDLINE | ID: mdl-29247068
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gut Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gut Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália